🔍
Nanoparticle Modification of Human Adipose-derived Mesenchymal Stem Cells for Brain Cancer and Other Neurological Diseases
Case ID:
C13152
Report of Invention:
7/9/2014
Web Published:
3/17/2022
Human Adipose-derived Mesenchymal Stem Cells can be engineered to synthesize and release anti-tumor proteins and therefore can be used as “Trojan Horses”. The inventors have created a novel technology which encompasses a solution containing biodegradable, polymeric nanoparticles that is combined with Freshly-extracted Adipose Tissue (F.A.T.) (from a patient, autologous cells). This technology non-virally engineers the F.A.T. including the primary hAMSCs contained within the F.A.T to secrete anti-cancer proteins while maintaining the cells' ability to migrate toward tumor cells. For future clinical application, the nanoparticles could be added ex vivo to hAMSCs obtained from patient fat after culturing for a few days and then the autologous cells administered IV as a treatment. Alternatively, the nanoparticle solution can be added to F.A.T. with the resulting mixture re-administered during surgery, without the cells being processed. This technology is more easily translatable than cell therapy approaches that require cell culturing and many FDA regulations. This is a revolutionary new way of treating patients with brain cancer and facilitating personalized medicine.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Nanoparticle Modification of Human Adipose-derived Mesenchymal Stem Cells for Treating Brain Cancer and Other Neurological Diseases
DIV: Divisional
United States
16/600,268
11,547,729
10/11/2019
1/10/2023
3/23/2037
Granted
Nanoparticle Modification of Human Adipose-derived Mesenchymal Stem Cells for Brain Cancer and Other Neurological Diseases
CON: Continuation
United States
18/075,940
12/6/2022
Pending
Direct Link:
https://jhu.technologypublisher.com/technology/46071
Inventors:
Category(s):
Clinical and Disease Specializations, Clinical and Disease Specializations > Neurology, Technology Classifications > Therapeutic Modalities > Cell Therapies, Technology Classifications > Therapeutic Modalities > Biologics, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Oncology > Brain Cancer, Clinical and Disease Specializations > Oncology > Glioma,
Get custom alerts for techs in these categories/from these inventors:
Subscribe for JHTV Updates
For Information, Contact:
Nakisha Holder
nickki@jhu.edu
410-614-0300
Save This Technology:
Bookmark this page
Download as PDF
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum